Effect of Acyclovir on HIV-1 Set Point among Herpes Simplex Virus Type 2-Seropositive Persons during Early HIV-1 Infection

被引：9

作者：

Kim, H. Nina ^{[1
,4
]}

Wang, Jing ^{[7
]}

Hughes, James ^{[7
]}

Coombs, Robert ^{[2
,4
,5
]}

Sanchez, Jorge ^{[11
]}

Reid, Stewart ^{[8
,12
]}

Delany-Moretlwe, Sinead ^{[13
]}

Cowan, Frances ^{[14
]}

Fuchs, Jonathan ^{[9
,11
]}

Eshleman, Susan H. ^{[10
]}

Khaki, Leila ^{[7
]}

McMahon, Moira A. ^{[10
]}

Siliciano, Robert F. ^{[10
]}

Wald, Anna ^{[4
,7
]}

Celum, Connie ^{[3
,4
,6
]}

机构：

[1] Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA

[2] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98104 USA

[3] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98104 USA

[4] Univ Washington, Sch Publ Hlth, Dept Med, Seattle, WA 98104 USA

[5] Univ Washington, Sch Publ Hlth, Dept Lab Med, Seattle, WA 98104 USA

[6] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98104 USA

[7] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA

[8] Univ Alabama, Dept Med, Birmingham, AL 35294 USA

[9] San Francisco Dept Publ Hlth, San Francisco, CA USA

[10] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

[11] Asociac Civil Impacta Salud & Educ IMPACTA, Lima, Peru

[12] Ctr Infect Dis Res Zambia, Lusaka, Zambia

[13] Univ Witwatersrand, Reprod Hlth Unit, Johannesburg, South Africa

[14] UCL, London, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2010年 / 202卷 / 05期

基金：

美国国家卫生研究院;

关键词：

REVERSE-TRANSCRIPTASE; SEROCONVERSION; ACQUISITION; RESISTANCE; MUTATION; COHORT; UGANDA; TRIAL; RAKAI; MEN;

D O I：

10.1086/655662

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We evaluated whether acyclovir suppression during human immunodeficiency virus type 1 (HIV-1) acquisition reduces HIV-1 set point, increases CD4 cell counts, and selects reverse-transcriptase mutations among 76 HIV-1 seroconverters identified in a placebo-controlled trial of twice-daily acyclovir (400 mg) for the prevention of HIV acquisition in herpes simplex virus type 2 (HSV-2)-seropositive persons (HIV Prevention Trials Network study 039). We found no significant difference in plasma HIV-1 RNA levels (Pp. 30) or CD4 cell counts (Pp. 85) between the acyclovir and placebo recipients. V75I and other mutations in HIV-1 reverse transcriptase reported from in vitro acyclovir studies were not observed. In conclusion, acyclovir suppression during HIV-1 seroconversion and the subsequent 6 months does not affect HIV-1 set point.

引用

页码：734 / 738

页数：5

共 50 条

[21] Recurrent Herpes Simplex Virus (HSV) Eyelid Infection in an HIV-1 Infected Patient
L. Milazzo
S. Trovati
S. Pedenovi
S. De Angelis
C. Parravicini
Infection, 2007, 35 : 393 - 394
[22] Recurrent herpes simplex virus (HSV) eyelid infection in an HIV-1 infected patient
Milazzo, L.
Trovati, S.
Pedenovi, S.
De Angelis, S.
Parravicini, C.
INFECTION, 2007, 35 (05) : 393 - 394
[23] Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women
Mayaud, P.
Nagot, N.
Konate, I.
Ouedraogo, A.
Weiss, H. A.
Foulongne, V.
Defer, M-C
Sawadogo, A.
Segondy, M.
Van de Perre, P
SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 (05) : 332 - 337
[24] Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection
Kiwanuka, Noah
Laeyendecker, Oliver
Robb, Merlin
Kigozi, Godfrey
Arroyo, Miguel
McCutchan, Francine
Eller, Leigh Anne
Eller, Michael
Makumbi, Fred
Birx, Deborah
Wabwire-Mangen, Fred
Serwadda, David
Sewankambo, Nelson K.
Quinn, Thomas C.
Wawer, Maria
Gray, Ronald
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05): : 707 - 713
[25] High levels of cervical HIV-1 RNA during early HIV-1 infection
Lavreys, Ludo
Baeten, Jared M.
Panteleeff, Dana D.
Richardson, Barbra A.
McClelland, R. Scott
Chohan, Varsha
Mandaliya, Kishorchandra
Ndinya-Achola, Jeckoniah O.
Overbaugh, Julie
AIDS, 2006, 20 (18) : 2389 - 2390
[26] Clinical and Virologic Response to Episodic Acyclovir for Genital Ulcers Among HIV-1 Seronegative, Herpes Simplex Virus Type 2 Seropositive African Women: A Randomized, Placebo-Controlled Trial
Baeten, Jared M.
Reid, Stewart E.
Delany-Moretlwe, Sinead
Hughes, James P.
Wang, Richard S.
Wilcox, Ellen
Limbada, Mohammed
Akpomiemie, Godspower
Corey, Lawrence
Wald, Anna
Celum, Connie
SEXUALLY TRANSMITTED DISEASES, 2012, 39 (01) : 21 - 24
[27] Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study)
Barnabas, Ruanne V.
Wasserheit, Judith N.
Huang, Yunda
Janes, Holly
Morrow, Rhoda
Fuchs, Jonathan
Mark, Karen E.
Casapia, Martin
Mehrotra, Devan V.
Buchbinder, Susan P.
Corey, Lawrence
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (03) : 238 - 244
[28] Genetic analysis of outbreak of hepatitis A virus infection among HIV-1 seropositive men
Koibuchi, T
Ishida, T
Nakamura, T
Ajisawa, A
Negishi, M
Kashiyama, T
Takechi, A
Iwamoto, A
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 1999, 52 (06) : 249 - 250
[29] Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe
Cowan, FF
Pascoe, SJS
Barlow, KL
Langhaug, LF
Jaffar, S
Hargrove, JW
Robinson, NJ
Latif, AS
Bassett, MT
Wilson, D
Brown, DWG
Hayes, RJ
AIDS, 2006, 20 (02) : 261 - 267
[30] Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania
Madebe, Rashid
Kiwelu, Ireen
Ndaro, Arnold
Francis, Filbert
Baraka, Vito
Theilgaard, Zahra
Katzenstein, Terese
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (04): : 398 - 403

← 1 2 3 4 5 →